Home > Share Market > Stocks > Nectar Lifescience Ltd > Financial Statements > NECLIFE Cash Flow

Nectar Lifescience Ltd Financial Statements

Nectar Lifescience Ltd Cash Flow Statement

  • Tabular Data
  • Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax (59) 37.50 62.70 67.40
Depreciation (60) (61) (64) (62)
Tax paid 11.50 (5.70) (10) (12)
Working capital 276 200 362 185
Other operating items -- -- -- --
Operating cashflow 168 171 349 178
Capital expenditure 646 417 233 79.80
Free cash flow 814 588 583 258
Equity raised 1,812 1,844 1,830 1,835
Investments (4.70) 0.21 0.41 0.32
Debt financing/disposal 425 (222) 77.40 22
Dividends paid -- -- 1.12 1.12
Other items -- -- -- --
Net in cash 3,046 2,210 2,492 2,116

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000